USA - NASDAQ:WGRX - US9495031067 - Common Stock
The current stock price of WGRX is 0.6041 USD. In the past month the price decreased by -26.76%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 24.1 | 100.35B | ||
| COR | CENCORA INC | 21.53 | 64.65B | ||
| CAH | CARDINAL HEALTH INC | 19.91 | 38.97B | ||
| HSIC | HENRY SCHEIN INC | 13.38 | 7.56B | ||
| AHCO | ADAPTHEALTH CORP | 29.5 | 1.24B | ||
| AHG | AKSO HEALTH GROUP | N/A | 873.23M | ||
| OMI | OWENS & MINOR INC | 3.56 | 401.26M | ||
| ATPC | AGAPE ATP CORP | N/A | 60.01M | ||
| COSM | COSMOS HEALTH INC | N/A | 27.26M | ||
| VRAX | VIRAX BIOLABS GROUP LTD | N/A | 2.49M | ||
| POM | POMDOCTOR LTD - ADR | N/A | 574.43M |
Wellgistics Health, Inc. operates as a holding company centered around pharmaceuticals and healthcare services. The company is headquartered in Tampa, Florida. The company went IPO on 2025-02-21. The company focuses on specialty medications and a community-based model offering home delivery services to patients. The company is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
WELLGISTICS HEALTH INC
3000 Bayport Drive Suite 950
Tampa FLORIDA US
Employees: 31
Phone: 18433021785
Wellgistics Health, Inc. operates as a holding company centered around pharmaceuticals and healthcare services. The company is headquartered in Tampa, Florida. The company went IPO on 2025-02-21. The company focuses on specialty medications and a community-based model offering home delivery services to patients. The company is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
The current stock price of WGRX is 0.6041 USD. The price decreased by -7.06% in the last trading session.
WGRX does not pay a dividend.
WGRX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
WELLGISTICS HEALTH INC (WGRX) currently has 31 employees.
WELLGISTICS HEALTH INC (WGRX) will report earnings on 2025-12-08.
Over the last trailing twelve months WGRX reported a non-GAAP Earnings per Share(EPS) of -0.9. The EPS decreased by -160.04% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -83.54% | ||
| ROE | -5004.11% | ||
| Debt/Equity | 11.16 |